COMP <GO>
MSA vs JNJ // FREE CASH FLOW YIELD
MSA Safety Incorporated (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: MSA 5
— JNJ 10
▲ FREE CASH FLOW YIELD LEADER: MSA
LAST: $178.57 (-0.33%) • MKT CAP: $6.91B
fcf-yield
4.27%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
fcf-yield
2.97%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MSA VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MSA | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 46.50% | 67.90% | -21.40 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.60% | 25.50% | -8.90 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 18.5x | -1.50 | MSA | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 4.27% | 2.97% | +1.30 | MSA | /fcf-yield <GO> |
| Operating Margin | 19.80% | 34.70% | -14.90 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 14.90% | 28.50% | -13.60 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 3.70% | 6.00% | -2.30 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.19% | 0.00% | +1.19 | MSA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.83 | 5.59 | +0.24 | MSA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 7.20% | -0.70 | MSA | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.1 | 60.4 | -16.27 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 1.08 | -0.21 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.1x | 23.0x | +0.10 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.91B | $662.49B | -$655.58B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MSA REV | JNJ REV | MSA GROSS % | JNJ GROSS % | MSA FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.87B | $94.19B | 46.5% | 67.9% | $295.4M | $19.70B |
| FY 2024 | $1.81B | $88.82B | 47.6% | 69.1% | $242.2M | $19.84B |
| FY 2023 | $1.79B | $85.16B | 44.0% | 44.0% | $12.4M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MSA // BETA 0.87
JNJ // BETA 1.08